A A
  • Contact Us
  • News & Updates
  • Careers
  • For Medical Professionals
Georgia Retina
  • 888-427-3846
  • Patient Portal
  • Doctor Portal
  • Pay My Bill
  • Home
  • Contact Us
  • Doctors
    • Michael S. Jacobson, M.D.
    • Scott I. Lampert, M.D.
    • Jay Stallman, M.D., F.A.C.S.
    • Mark J. Rivellese, M.D.
    • Sean S. Koh, M.D.
    • Atul Sharma, M.D.
    • Robert Stoltz, M.D., Ph. D.
    • John J. Miller, M.D.
    • Stephanie Vanderveldt, M.D.
    • Hyung Cho, M.D.
    • Krishna Mukkamala, M.D.
    • David S. Chin Yee, M.D.
    • Paul S. Walia, M.D.
    • Yogin Patel, M.D.
    • Gregory D. Lee, M.D.
    • Ella H. Leung, M.D.
  • Locations
    • Cartersville
    • Conyers
    • Cumming
    • Douglasville
    • Gainesville
    • Gwinnett (Lawrenceville)
    • Macon
    • Marietta
    • Northside
    • Peachtree City
    • Stockbridge
    • Surgery Center
    • Tucker
  • Conditions
    • Age-Related Macular Degeneration
    • Branch Retinal Vein Occlusion
    • Central Retinal Vein Occlusion
    • Central Serous Retinopathy
    • Cystoid Macular Edema
    • Diabetic Retinopathy
    • Macular Holes
    • Macular Pucker
    • Ocular Histoplasmosis
    • Retinal Detachment
    • Retinopathy of Prematurity
    • Tumors of the Eye
    • Uveitis
  • Patient Education
    • About the Eye
    • Amsler Recording Chart
    • Conditions
    • Surgical Services
    • Educational Videos
    • Useful Links
    • Testimonials
  • Clinical Trials
  • For Medical Professionals
    • Doctor Portal
  • Menu

Clinical Trials

Georgia Retina has a long history of commitment to and participation in clinical trials in order to provide our patients access to new, state-of-the-art preventative, or therapeutic treatments. We partner with the National Eye Institute, some of the nation’s top pharmaceutical companies, and other clinical practices to explore the causes and cures for many retinal conditions.

We take special care to ensure that our study patients experience the best medical care possible.

About Our Research

Georgia Retina continues its dedication to the advancement of ophthalmic science and patient care through the active participation in well-designed, randomized, controlled clinical trials. Participation in clinical research trials helps to bring new and innovative therapies for many blinding conditions into clinical practice and to our patients.

If you are interested in determining your eligibility for a trial, please contact our Clinical Research Coordinator, Leslie Marcus, CCRC at (404) 299-5209.

Active Trials

Wet Age-Related Macular Degeneration

  • Allergan 150998-005 CEDAR
  • Genentech GR40548 ARCHWAY
  • Genentech GR40844 LUCERNE
  • Graybug GBV-102-002 Altissimo
  • Xbrane XBR1002 XPLORE

Dry Age-Related Macular Degeneration

  • Gemini GEN-MH-001 Clarity 1
  • Gemini GEN-MH-001 Clarity 2

Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Apellis APL2-303 DERBY
  • Genentech GR40973 Gallego
  • Gyroscope Therapeutics GTSCOPE
  • Ophthotech OPH2003

Retinal Vein Occlusion

  • Novartis CRTH258C2302 Raven
  • SCORE2

Diabetic Macular Edema

  • Genentech GR40349 YOSEMITE
  • Novartis CRTH258B2305 Kingfisher

Diabetic Retinopathy

  • Novo Nordisk NN9535-4352 FOCUS

Past Trials

  • AART C-02-60
  • Acucela 4429-202 SEATTLE
  • Aerpio AKB-9778-CI-5001 TIME-2b
  • Allergan 1771-201-008 MAPLE
  • Allergan 190342-038 BEACON
  • ALLERGAN 206207-012
  • AREDS2
  • AREDS2 ForeseeHome
  • C-09-067 RACE
  • DRCR.net Protocol N
  • Genentech, Inc. GR39821
  • HORIZON FVF3426g
  • KalVista KVD011-201
  • LFG316A2203
  • MARINA FVF2598g
  • Novartis CSPP100A2244
  • Ocriplasmin Research to Better Inform Treatment (ORBIT)
  • OPH1002
  • OPH1004
  • PDEX
  • Regeneron R2176-3-AMD-1417 CAPELLA
  • Regeneron R910-3-AMD-1517 ONYX
  • Regeneron R910-3-DME-1518 RUBY
  • Regeneron VGFTe-OD-1411 PANORAMA
  • RIDE FVF4168g
  • RISE FVF4170g
  • Roche BP30099 BOULEVARD
  • Roche GX29176 CHROMA
  • Roche GX30191 OMASPECT
  • Roche BP29647 AVENUE
  • SAILOR FVF3689g
  • SCORE
  • Suprachoroidal Buckling for Retinal Detachment
  • Taiwan Liposome Company(TLC) TLC399A2002
  • Xcenda C-01-17 ForeseeHome

Research Coordinators

  • Leslie Marcus, CCRC
  • Caitlin Harrison, CCRC, COA
  • Stephanie Campbell, CRC, COA

Active Trials

  • Allergan 150998-005 CEDAR
  • Apellis APL2-303 DERBY
  • Gemini GEM-NH-001 CLARITY 1
  • Gemini GEM-NH-001 CLARITY 2
  • Genentech GR40973 Gallego
  • Graybug GBV-102-002 Altissimo
  • Novartis CRTH258C2302 Raven
  • Novartis CRTH258B2305 Kingfisher
  • Ophthotech OPH2003
  • SCORE2

Past Trials

  • AART C-02-60
  • Acucela 4429-202 SEATTLE
  • Aerpio AKB-9778-CI-5001 TIME-2b
  • Allergan 1771-201-008 MAPLE
  • Allergan 190342-038 BEACON
  • ALLERGAN 206207-012
  • AREDS2
  • AREDS2 ForeseeHome
  • C-09-067 RACE
  • DRCR.net Protocol N
  • Genentech GR39821
  • HORIZON FVF3426g
  • KalVista KVD011-201
  • LFG316A2203
  • MARINA FVF2598g
  • Novartis CSPP100A2244
  • Ocriplasmin Research to Better Inform Treatment (ORBIT)
  • OPH1002
  • OPH1004
  • PDEX
  • Regeneron R2176-3-AMD-1417 CAPELLA
  • Regeneron R910-3-AMD-1517 ONYX
  • Regeneron R910-3-DME-1518 RUBY
  • Regeneron VGFTe-OD-1411 PANORAMA
  • RIDE FVF4168g
  • RISE FVF4170g
  • Roche BP29647 AVENUE
  • Roche BP 30099 BOULEVARD
  • Roche GX29176 CHROMA
  • Roche GX30191 OMASPECT
  • SAILOR FVF3689g
  • SCORE
  • Suprachoroidal Buckling for Retinal Detachment
  • Taiwan Liposome Company (TLC) TLC399A2002
  • Xcenda C-01-17 ForeseeHome
© 2019 Georgia Retina
  • Facebook
  • Privacy Notice
  • Notice of Non-Discrimination
  • Disclaimer
Scroll to top